VUMERITY Trademark

Trademark Overview

On Tuesday, June 6, 2017, a trademark application was filed for VUMERITY with the United States Patent and Trademark Office. The USPTO has given the VUMERITY trademark a serial number of 87476946. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, October 9, 2025. This trademark is owned by Alkermes Pharma Ireland Limited. The VUMERITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparations for the treatment of multiple sclerosis
vumerity

General Information

Serial Number87476946
Word MarkVUMERITY
Filing DateTuesday, June 6, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, October 9, 2025
Registration Number5908620
Registration DateTuesday, November 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparations for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 13, 2017
Primary Code005
First Use Anywhere DateMonday, July 29, 2019
First Use In Commerce DateMonday, July 29, 2019

Trademark Owner History

Party NameBIOGEN MA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlkermes Pharma Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDUBLIN
IE
Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDUBLIN
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDUBLIN
IE

Trademark Events

Event DateEvent Description
Friday, June 9, 2017NEW APPLICATION ENTERED
Tuesday, June 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 21, 2017ASSIGNED TO EXAMINER
Monday, July 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 9, 2018SOU TEAS EXTENSION RECEIVED
Friday, March 9, 2018SOU EXTENSION 1 FILED
Friday, March 9, 2018SOU EXTENSION 1 GRANTED
Tuesday, March 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 26, 2018SOU TEAS EXTENSION RECEIVED
Friday, October 26, 2018SOU EXTENSION 2 FILED
Friday, October 26, 2018SOU EXTENSION 2 GRANTED
Tuesday, October 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 21, 2019SOU TEAS EXTENSION RECEIVED
Thursday, February 21, 2019SOU EXTENSION 3 FILED
Thursday, February 21, 2019SOU EXTENSION 3 GRANTED
Saturday, February 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, August 20, 2019USE AMENDMENT FILED
Tuesday, September 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 17, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, October 4, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 5, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 12, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, March 4, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, March 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, May 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 30, 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Thursday, June 5, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, October 9, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 9, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, October 9, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

vumerity pharmaceutical treatment preparations sclerosis multiple neurologic disorders